PDE5A inhibition attenuates cardiac hypertrophy and hypertrophy signaling cascades in vivo

被引：0
|
作者：
Takimoto, E
Champion, HC
Li, MX
Belardi, DF
Ren, SX
Wang, YB
Kass, DA
机构：
[1] Johns Hopkins Univ, Inst Med, Baltimore, MD USA
[2] Univ Calif Los Angeles, Los Angeles, CA USA
来源：
CIRCULATION | 2004年 / 110卷 / 17期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
298
引用
收藏
页码：64 / 65
页数：2
相关论文
共 50 条
  • [31] Cardiac Ankyrin Repeat Protein Attenuates Cardiac Hypertrophy by Inhibition of ERK1/2 and TGF-β Signaling Pathways
    Song, Yao
    Xu, Jialin
    Li, Yanfeng
    Jia, Chunshi
    Ma, Xiaowei
    Zhang, Lei
    Xie, Xiaojie
    Zhang, Yong
    Gao, Xiang
    Zhang, Youyi
    Zhu, Dahai
    PLOS ONE, 2012, 7 (12):
  • [32] Inhibition of mTOR signaling with rapamycin attenuates renal hypertrophy in the early diabetic mice
    Sakaguchi, M
    Isono, M
    Isshiki, K
    Sugimoto, T
    Koya, D
    Kashiwagi, A
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2006, 340 (01) : 296 - 301
  • [33] MicroRNA-19a/b-3p protect the heart from hypertension-induced pathological cardiac hypertrophy through PDE5A
    Liu, Kun
    Hao, Qiongyu
    Wei, Jie
    Li, Gong-Hao
    Wu, Yong
    Zhao, Yun-Feng
    JOURNAL OF HYPERTENSION, 2018, 36 (09) : 1847 - 1857
  • [34] Isoliquiritigenin attenuates pathological cardiac hypertrophy via regulating AMPKα in vivo and in vitro
    Gao, Meiling
    Cai, Qiang
    Si, Haichao
    Shi, Si
    Wei, Huixia
    Lv, Miaomiao
    Wang, Xiaofan
    Dong, Tieli
    JOURNAL OF MOLECULAR HISTOLOGY, 2022, 53 (04) : 679 - 689
  • [35] Administration of antioxidants attenuates pressure-overload induced cardiac hypertrophy in vivo
    Zhao, AQ
    Ha, TZ
    Li, YH
    Gao, X
    Kelley, J
    Williams, DL
    Browder, IW
    Li, CF
    FASEB JOURNAL, 2005, 19 (04): : A705 - A705
  • [36] Isoliquiritigenin attenuates pathological cardiac hypertrophy via regulating AMPKα in vivo and in vitro
    Meiling Gao
    Qiang Cai
    Haichao Si
    Si Shi
    Huixia Wei
    Miaomiao Lv
    Xiaofan Wang
    Tieli Dong
    Journal of Molecular Histology, 2022, 53 : 679 - 689
  • [37] Inhibition of Jak2 phosphorylation attenuates pressure overload cardiac hypertrophy
    Beckles, Daniel L.
    Mascareno, Eduardo
    Siddiqui, M. A. Q.
    VASCULAR PHARMACOLOGY, 2006, 45 (06) : 350 - 357
  • [38] Selective inhibition of HDAC2 by magnesium valproate attenuates cardiac hypertrophy
    Raghunathan, Suchi
    Goyal, Ramesh K.
    Patel, Bhoomika M.
    CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2017, 95 (03) : 260 - 267
  • [39] miR-29a attenuates cardiac hypertrophy through inhibition of PPAR expression
    Zhang, Si
    Yin, Zhongnan
    Dai, Fei-Fei
    Wang, Hao
    Zhou, Meng-Jiao
    Yang, Ming-Hui
    Zhang, Shu-Feng
    Fu, Zhi-Feng
    Mei, Ying-Wu
    Zang, Ming-Xi
    Xue, Lixiang
    JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (08) : 13252 - 13262
  • [40] Reply to Kass and Takimoto: Cardiac hypertrophy without cGKI and PDE5 in cardiac myocytes
    Lukowski, Robert
    Rybalkin, Sergei D.
    Beavo, Joseph A.
    Hofmann, Franz
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (24) : E99 - E99
12345